Ipratropium Bromide

A type of anticholinergic medication that works by relaxing the muscles in the airways, making it easier to breathe.

Treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Relief of bronchospasm in asthma.

Prevention of exerciseinduced bronchospasm in patients with asthma.

This combination medication works by relaxing the muscles in the airways, which helps to open up the airways and make it easier to breathe. Ipratropium bromide blocks the action of acetylcholine, a neurotransmitter that causes airway constriction. Levosalbutamol stimulates beta-2 receptors in the airways, causing the muscles to relax.

Store at room temperature, between 15-30°C (59-86°F), away from direct sunlight and moisture. Keep out of reach of children. Do not use after the expiry date printed on the label.

The dosage and frequency of administration will be determined by your doctor based on your individual needs and condition.

This medication is typically inhaled using a nebulizer or a metered-dose inhaler.

Follow your doctor's instructions carefully and do not exceed the prescribed dosage.

Dry mouth

Headache

Nausea

Tremor

Increased heart rate

Coughing

Sore throat

Muscle cramps

Insomnia

Anxiety

Alcohol Consumption

Alcohol can worsen the side effects of this medication. Avoid alcohol consumption while taking this medication.



While Driving or Operating Machinery

This medication may cause dizziness, drowsiness, and blurred vision. Avoid driving or operating machinery until you know how this medication affects you.



Pregnant & Breastfeeding Women

Talk to your doctor before using this medication if you are pregnant or breastfeeding. It is not recommended for use during pregnancy unless the benefits outweigh the risks. It is unknown if this medication passes into breast milk.



Children

This medication is not recommended for use in children under the age of 12 years.



Kidney

This medication is not recommended for use in patients with severe kidney disease.



Liver

This medication is not recommended for use in patients with severe liver disease.

Your doctor or pharmacist.

The medication leaflet provided with your medication.

The website of the U.S. Food and Drug Administration (FDA).